BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9010025)

  • 1. Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model.
    Hyytinen ER; Thalmann GN; Zhau HE; Karhu R; Kallioniemi OP; Chung LW; Visakorpi T
    Br J Cancer; 1997; 75(2):190-5. PubMed ID: 9010025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic abnormalities specifically associated with varying metastatic potential of prostate cancer cell lines as detected by comparative genomic hybridization.
    Chu LW; Pettaway CA; Liang JC
    Cancer Genet Cytogenet; 2001 Jun; 127(2):161-7. PubMed ID: 11425457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis.
    Thalmann GN; Sikes RA; Wu TT; Degeorges A; Chang SM; Ozen M; Pathak S; Chung LW
    Prostate; 2000 Jul; 44(2):91-103 Jul 1;44(2). PubMed ID: 10881018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stepwise genetic changes associated with progression of nontumorigenic HPV-18 immortalized human prostate cancer-derived cell line to a malignant phenotype.
    Hukku B; Mally M; Cher ML; Peehl DM; Kung H; Rhim JS
    Cancer Genet Cytogenet; 2000 Jul; 120(2):117-26. PubMed ID: 10942801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells.
    Wu HC; Hsieh JT; Gleave ME; Brown NM; Pathak S; Chung LW
    Int J Cancer; 1994 May; 57(3):406-12. PubMed ID: 8169003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.
    Thalmann GN; Anezinis PE; Chang SM; Zhau HE; Kim EE; Hopwood VL; Pathak S; von Eschenbach AC; Chung LW
    Cancer Res; 1994 May; 54(10):2577-81. PubMed ID: 8168083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permanent phenotypic and genotypic changes of prostate cancer cells cultured in a three-dimensional rotating-wall vessel.
    Rhee HW; Zhau HE; Pathak S; Multani AS; Pennanen S; Visakorpi T; Chung LW
    In Vitro Cell Dev Biol Anim; 2001 Mar; 37(3):127-40. PubMed ID: 11370803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the malignant phenotype and genotype of the human androgen-independent cell line DU 145 and a subline derived from metastasis after orthotopic implantation in nude mice.
    Bex A; Wullich B; Endris V; Otto T; Rembrink K; Stöckle M; Rübben H
    Cancer Genet Cytogenet; 2001 Jan; 124(2):98-104. PubMed ID: 11172899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
    Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased androgen-responsive growth of human prostate cancer is associated with increased genetic alterations.
    Karan D; Schmied BM; Dave BJ; Wittel UA; Lin MF; Batra SK
    Clin Cancer Res; 2001 Nov; 7(11):3472-80. PubMed ID: 11705865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization.
    Laitinen S; Karhu R; Sawyers CL; Vessella RL; Visakorpi T
    Genes Chromosomes Cancer; 2002 Sep; 35(1):66-73. PubMed ID: 12203791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive genotypic analysis of human prostate cancer cell lines and sublines derived from metastases after orthotopic implantation in nude mice.
    Lensch R; Götz C; Andres C; Bex A; Lehmann J; Zwergel T; Unteregger G; Kamradt J; Stoeckle M; Wullich B
    Int J Oncol; 2002 Oct; 21(4):695-706. PubMed ID: 12239607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line.
    Bae VL; Jackson-Cook CK; Maygarden SJ; Plymate SR; Chen J; Ware JL
    Prostate; 1998 Mar; 34(4):275-82. PubMed ID: 9496902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of metastatic and non-metastatic tumor lines from a patient's prostate cancer specimen-identification of a small subpopulation with metastatic potential in the primary tumor.
    Lin D; Bayani J; Wang Y; Sadar MD; Yoshimoto M; Gout PW; Squire JA; Wang Y
    Prostate; 2010 Nov; 70(15):1636-44. PubMed ID: 20564316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.
    Xia W; Unger P; Miller L; Nelson J; Gelman IH
    Cancer Res; 2001 Jul; 61(14):5644-51. PubMed ID: 11454719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor modifications in prostate cancer cells upon long-termandrogen ablation and antiandrogen treatment.
    Marques RB; Erkens-Schulze S; de Ridder CM; Hermans KG; Waltering K; Visakorpi T; Trapman J; Romijn JC; van Weerden WM; Jenster G
    Int J Cancer; 2005 Nov; 117(2):221-9. PubMed ID: 15900601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
    Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
    Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver metastatic ability of human melanoma cell line is associated with losses of chromosomes 4, 9p21-pter and 10p.
    Adám Z; Adány R; Ladányi A; Tímár J; Balázs M
    Clin Exp Metastasis; 2000; 18(4):295-302. PubMed ID: 11448059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
    Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ
    Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.